Impact of the COVID-19 pandemic on bone and soft tissue tumor treatment: A single-institution study.

Yoshitaka BanManabu HoshiNaoto OebisuAkiyoshi ShimataniNaoki TakadaTadashi IwaiHiroaki Nakamura

Published in: PloS one (2023)

The COVID-19 pandemic has been recognized throughout the world to have adverse effects in a variety of areas. It had a negative impact on hospital costs and the length of hospital stay in the field of bone and soft tissue tumor treatment.

Keyphrases

soft tissue
healthcare
adverse drug
bone loss
replacement therapy
acute care